Literature DB >> 15316518

Clinical features and severity grading of anaphylaxis.

Simon G A Brown1.   

Abstract

BACKGROUND: Existing grading systems for acute systemic hypersensitivity reactions vary considerably, have a number of deficiencies, and lack a consistent definition of anaphylaxis.
OBJECTIVE: The aims of this study were to develop a simple grading system and definition of anaphylaxis and to identify predictors of reaction severity.
METHODS: Case records from 1149 systemic hypersensitivity reactions presenting to an emergency department were analyzed retrospectively. Logistic regression analyses of the associations between individual reaction features and hypotension and hypoxia were used to construct a grading system. Epinephrine use, etiology, age, sex, comorbidities, and concurrent medications were then assessed for their association with reaction grade.
RESULTS: Confusion, collapse, unconsciousness, and incontinence were strongly associated with hypotension and hypoxia and were used to define severe reactions. Diaphoresis, vomiting, presyncope, dyspnea, stridor, wheeze, chest/throat tightness, nausea, vomiting, and abdominal pain had weaker, albeit significant, associations and were used to define moderate reactions. Reactions limited to the skin (urticaria, erythema, and angioedema) were defined as mild. These grades correlated well with epinephrine usage. Older age, insect venom, and iatrogenic causes were independent predictors of severity. Preexisting lung disease was associated with an increased risk of hypoxia.
CONCLUSION: This simple grading system has potential value for defining reaction severity in clinical practice and research settings. The moderate and severe grades provide a workable definition of anaphylaxis. Age, reaction precipitant, and preexisting lung disease appear to be the major determinants of reaction severity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15316518     DOI: 10.1016/j.jaci.2004.04.029

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  155 in total

1.  Multiple epinephrine doses for stinging insect hypersensitivity reactions treated in the emergency department.

Authors:  Susan A Rudders; Aleena Banerji; Daniel P Katzman; Sunday Clark; Carlos A Camargo
Journal:  Ann Allergy Asthma Immunol       Date:  2010-07       Impact factor: 6.347

Review 2.  H1-antihistamines for the treatment of anaphylaxis with and without shock.

Authors:  A Sheikh; V m ten Broek; S G A Brown; F E R Simons
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

3.  Anaphylaxis as an adverse event following immunisation.

Authors:  Michel Erlewyn-Lajeunesse; Jan Bonhoeffer; Jens U Ruggeberg; Paul T Heath
Journal:  J Clin Pathol       Date:  2007-05-04       Impact factor: 3.411

4.  Ofatumumab for the treatment of childhood nephrotic syndrome.

Authors:  Chia-Shi Wang; Rochelle Schmidt Liverman; Rouba Garro; Roshan Punnoose George; Anastacia Glumova; Alana Karp; Stephanie Jernigan; Barry Warshaw
Journal:  Pediatr Nephrol       Date:  2017-02-17       Impact factor: 3.714

5.  Diagnostic utility of two case definitions for anaphylaxis: a comparison using a retrospective case notes analysis in the UK.

Authors:  Michel Erlewyn-Lajeunesse; Sandra Dymond; Ingrid Slade; Helen L Mansfield; Rosie Fish; Owen Jones; Jonathan R Benger
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

Review 6.  Diagnostic tools for hypersensitivity to platinum drugs and taxanes: skin testing, specific IgE, and mast cell/basophil mediators.

Authors:  Joana Caiado; Matthieu Picard
Journal:  Curr Allergy Asthma Rep       Date:  2014-08       Impact factor: 4.806

7.  Paediatric emergency department anaphylaxis: different patterns from adults.

Authors:  S C Braganza; J P Acworth; D R L Mckinnon; J E Peake; A F T Brown
Journal:  Arch Dis Child       Date:  2005-11-24       Impact factor: 3.791

Review 8.  [Emergency treatment and management of anaphylaxis].

Authors:  K Brockow; J Ring
Journal:  Hautarzt       Date:  2013-02       Impact factor: 0.751

Review 9.  Immediate-type hypersensitivity drug reactions.

Authors:  Shelley F Stone; Elizabeth J Phillips; Michael D Wiese; Robert J Heddle; Simon G A Brown
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

10.  Risk of peanut- and tree-nut-induced anaphylaxis during Halloween, Easter and other cultural holidays in Canadian children.

Authors:  Mélanie Leung; Ann E Clarke; Sofianne Gabrielli; Judy Morris; Jocelyn Gravel; Rodrick Lim; Edmond S Chan; Ran D Goldman; Paul Enarson; Andrew O'Keefe; Jennifer Gerdts; Derek Chu; Julia Upton; Xun Zhang; Greg Shand; Moshe Ben-Shoshan
Journal:  CMAJ       Date:  2020-09-21       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.